VKH
ALXN

Virtu KCG Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Virtu KCG Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,000
Closed -$348K – 4385
2013
Q3 		$348K Buy
+3,000
New +$329K ﹤0.01% 2443

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Virtu KCG Holdings's ALXN Position: Q2 2017 in Review

Virtu KCG Holdings increased its Alexion Pharmaceuticals (ALXN) stake by 602% in Q2 2017, buying an estimated $2.66M and bringing the position to 26,640 shares worth $3.24M. The position accounts for 0.09% of the portfolio, ranked #120.

Virtu KCG Holdings first reported a position in ALXN in Q3 2013 and has held it in 13 quarters since. The position peaked at $3.44M in Q3 2016. 559 funds tracked by Wall St. Rank hold ALXN as of Q2 2017.

  • Virtu KCG Holdings held 26,640 shares of Alexion Pharmaceuticals worth $3.24M as of Q2 2017.
  • Virtu KCG Holdings bought 22,845 Alexion Pharmaceuticals shares in Q2 2017, an estimated $2.66M.
  • Alexion Pharmaceuticals made up 0.09% of Virtu KCG Holdings's portfolio in Q2 2017, its #120 holding.
  • Virtu KCG Holdings first reported a position in Alexion Pharmaceuticals in Q3 2013 and has held it in 13 quarters since.
  • Virtu KCG Holdings's Alexion Pharmaceuticals position peaked at $3.44M in Q3 2016.
  • 559 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.